Skip to main content
VCbacked
Log inGet Started

Triana Biomedicines

Lexington, United States

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

$120.0M raised
Dec 2025
Series B
BiopharmaBiotechnologyPharmaceuticalTherapeutics

Top Investors

Lightspeed Venture PartnersRA Capital ManagementBessemer Venture PartnersInvusAscenta Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Triana Biomedicines

How much funding has Triana Biomedicines raised?
Triana Biomedicines has raised $120.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Who are Triana Biomedicines's investors?
Triana Biomedicines's investors include Lightspeed Venture Partners, RA Capital Management, Bessemer Venture Partners, Invus, Ascenta Capital.
Where is Triana Biomedicines headquartered?
Triana Biomedicines is headquartered in Lexington, United States.
What does Triana Biomedicines do?
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
What stage is Triana Biomedicines at?
Triana Biomedicines is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Triana Biomedicines — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/triana-biomedicines. Accessed June 4, 2026.
APA
VCBacked. (2025). Triana Biomedicines — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/triana-biomedicines
Wikipedia (cite web)
{{cite web |title=Triana Biomedicines — Funding & Investors |url=https://www.vcbacked.co/company/triana-biomedicines |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego